Speaker Profile
Ph.D., Founder, CEO, Endless Health
Biography
Cooper Galvin, Ph.D., is Co-Founder and Chief Executive Officer of Endless Health, a precision-health company using advanced molecular testing and personalized coaching to help individuals understand and improve cardiometabolic risk. A biophysicist and entrepreneur, he has worked across biotechnology, population health, and healthcare strategy, with a focus on translating complex biological measurements into decisions that people can use. Dr. Galvin earned a Ph.D. in Molecular Biophysics at Stanford University and an M.S. in Bioengineering from Stanford Engineering. He previously worked at McKinsey & Company and has also conducted population-health research. His entrepreneurial work includes Endless Health and related diagnostic initiatives designed to make high-information testing more accessible outside traditional specialty care. Dr. Galvin’s interests span molecular assays, preventive medicine, longitudinal health data, and the design of consumer-facing systems that connect measurement with behavior and clinical follow-up. His work reflects a broader effort to shift precision medicine upstream, from treating established disease toward earlier risk identification and prevention.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Nir Barzilai, Albert Einstein & Mike Snyder, Stanford
PMWC Award Ceremony
• Alexander (Zan) Fleming, Hevolution Foundation (Pioneer)
• Daniel Drucker, Sinai Health (Pioneer)
• Andrea Maier, NUS Yong Loo Lin School of Medicine (Luminary)
Featured Speakers
• Nir Barzilai, Albert Einstein
• Mike Snyder, Stanford
• Andrea Maier, NUS Yong Loo Lin School of Medicine
• Sara Espinoza, Cedars-Sinai
• Brian Kennedy, Buck Institute
• John Newman, Buck Institute / UCSF
• Marco Quarta, Rubedo Life Sciences
• Maria Dermit, Novo Nordisk
• Alan Shuldiner, Regeneron
• David Furman, Stanford
• Steve Horvath, UCLA
• Daniel Belsky, Columbia
• Ahmed Metwally, Google
• Lee Hood, Phenome Health / ISB
• George Slavich, UCLA
Targeting Aging Biology
What is actually druggable today, and what remains wishful thinking.
From Metabolism to Longevity: GLP-1 and Beyond
Incretins reshaping cardiometabolic prevention and healthy aging.
Which Aging Measures Matter?
Biological-age measures and biomarkers that can change clinical decisions.
Wearables & Digital Biomarkers at Scale
Continuous phenotyping and longitudinal signals in real-world aging.
Clinical Translation
Trials, endpoints, regulation, and the hard road to credible longevity medicine.
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
